Ketamine in the Treatment of Suicidal Depression

Clinical trial NCT01700829 · COMPLETED

Trial details

NCT number: NCT01700829
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder Suicidal Ideation

Start date: 2012-06-01
Primary completion: 2017-01-12
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.